CDSCO bans 35 unapproved Fixed Dose Combinations (FDCs) due to health risks. Immediate halt to production and sale ordered. Check the full list.

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. There are people who have played Baldur's Gate 3 more than me, but I feel pretty good about ...

A 12mg dose led to six per cent weight loss over the 10 months, and a 3mg dose five per cent. People taking a fake pill lost 1.6 per cent. The popularity of GLP-1 slimming injections has rocketed ...

Orforglipron significantly reduced HbA1c levels by 1.3% (3mg), 1.6% (12mg), and 1.5% (36mg) compared with 0.1% in the placebo arm. Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1 ...

Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a T2D application to follow in 2026.

In a 40-week study, more than 500 people with type 2 diabetes were given either a placebo or one of three possible doses (3mg, 12mg and 36mg) of the drug, orforglipron. Those taking the highest ...

The trial randomized 559 participants to receive either 3 mg, 12 mg, or 36 mg orforglipron or placebo. Also Read: Eli Lilly’s Mounjaro Launch Triggers Weight-Loss Drug Craze In India ...

GlobalData is the parent company of Clinical Trials Arena. In the randomised, placebo-controlled, double-blind ACHIEVE-1 trial (NCT05971940), the efficacy and safety of three doses – 3mg, 12mg and ...